1. Home
  2. RMNI vs SLDB Comparison

RMNI vs SLDB Comparison

Compare RMNI & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMNI
  • SLDB
  • Stock Information
  • Founded
  • RMNI 2005
  • SLDB 2013
  • Country
  • RMNI United States
  • SLDB United States
  • Employees
  • RMNI N/A
  • SLDB N/A
  • Industry
  • RMNI Business Services
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RMNI Consumer Discretionary
  • SLDB Health Care
  • Exchange
  • RMNI Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • RMNI 368.8M
  • SLDB 234.8M
  • IPO Year
  • RMNI N/A
  • SLDB 2018
  • Fundamental
  • Price
  • RMNI $3.36
  • SLDB $2.77
  • Analyst Decision
  • RMNI Buy
  • SLDB Strong Buy
  • Analyst Count
  • RMNI 2
  • SLDB 9
  • Target Price
  • RMNI $6.00
  • SLDB $15.67
  • AVG Volume (30 Days)
  • RMNI 209.0K
  • SLDB 1.5M
  • Earning Date
  • RMNI 05-01-2025
  • SLDB 05-19-2025
  • Dividend Yield
  • RMNI N/A
  • SLDB N/A
  • EPS Growth
  • RMNI N/A
  • SLDB N/A
  • EPS
  • RMNI N/A
  • SLDB N/A
  • Revenue
  • RMNI $426,212,000.00
  • SLDB N/A
  • Revenue This Year
  • RMNI $0.74
  • SLDB N/A
  • Revenue Next Year
  • RMNI $4.46
  • SLDB $569.02
  • P/E Ratio
  • RMNI N/A
  • SLDB N/A
  • Revenue Growth
  • RMNI N/A
  • SLDB N/A
  • 52 Week Low
  • RMNI $1.53
  • SLDB $2.45
  • 52 Week High
  • RMNI $4.15
  • SLDB $10.99
  • Technical
  • Relative Strength Index (RSI)
  • RMNI 48.96
  • SLDB 41.62
  • Support Level
  • RMNI $3.22
  • SLDB $3.01
  • Resistance Level
  • RMNI $3.45
  • SLDB $4.35
  • Average True Range (ATR)
  • RMNI 0.21
  • SLDB 0.47
  • MACD
  • RMNI 0.01
  • SLDB 0.01
  • Stochastic Oscillator
  • RMNI 57.14
  • SLDB 14.18

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: